Skip to main content
. 2017 Nov 28;23(44):7818–7829. doi: 10.3748/wjg.v23.i44.7818

Figure 2.

Figure 2

Validation of OncoScan copy number aberration data. The CNAs of (A) MDM2, (B) KRAS, (C) MYC, and (D) RRM2 in early-stage HCC were validated by TaqMan copy number assay. Correlations between OncoScan CNAs and TaqMan PCR-determined CNAs were calculated via Pearson’s correlation r and P-value. The X-axis shows the CNA results from TaqMan PCR and the Y-axis shows that of the OncoScan data. CNA: Copy number aberration.